Back

Effects of dapagliflozin on renal function in heart transplant recipients.

17 May 2025 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: ePosters in cardiovascular disease in special populations (3) Renal Failure and Cardiovascular Disease HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Miss Aleksandra Gutowska

University Clinical Centre UCK, Gdansk (Poland)

4 More presentations in this session

Presentation thumbnail
Histopathologic insights into AVF functionality and heart failure in end-stage renal disease
Mrs V. Samsone (Vilnius, LT)
Abstract Slides Video
Presentation thumbnail
Chemotherapy versus tumour burden: evaluating their roles in cardiovascular risk enhancement for breast cancer patients
Doctor R. Fernandes (Coimbra, PT)
Abstract Slides Video
Presentation thumbnail
Effect of finerenone on morbidity and mortality in chronic kidney disease and type 2 diabetes: FINE-HEART analysis of 3 randomized clinical trials
Doctor J. Ostrominski (Boston, US)
Abstract Slides
Presentation thumbnail
Exploring the hemoglobin-cardiovascular link in chronic kidney disease patients
Doctor T. Pereira dos Santos (Coimbra, PT)
Abstract Slides Video

Access the full session

Session thumbnail
ePosters in cardiovascular disease in special populations (3)

The Event

Event poster

Heart Failure 2025

17 May - 20 May 2025
You may be interested in
thumbnail
Congress Presentation
Microalbuminuria in heart transplant recipients -insights from the randomized trial dapagliflozin for renal protection in heart transplant recipients (DAPARHT)
thumbnail
Congress Presentation
Baseline characteristics of the first one hundred and two patients enrolled in the trial DAPAgliflozin for Renal protection in Heart Transplant recipients (DAPARHT)
thumbnail
Congress Presentation
Children after kidney transplantation show severe cardiac alterations

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources